ADP (adenosine Diphosphate) Receptor Antagonist Platelet Aggregation Inhibitors

ADP (adenosine diphosphate) receptor antagonist platelet aggregation inhibitors are a class of antiplatelet agent used to prevent blood clots in those with severe chest pain or who are at risk of stroke, heart attack, or other adverse vascular events. They function by inhibiting some or all types of adenosine diphosphate receptors, thinning the blood and improving arterial circulation. Commonly prescribed ADP (adenosine diphosphate) receptor antagonist platelet aggregation inhibitors include Effient (prasugrel) and Brilinta (ticagrelor).

Drugs classified as ADP (adenosine Diphosphate) Receptor Antagonist Platelet Aggregation Inhibitors are frequently used to treat the following conditions:

• Stroke
• Heart Attack
• Peripheral Artery Disease
• myocardial infarction prophylaxis
• thrombosis prophylaxis
• acute myocardial infarction, STEMI
• acute myocardial infarction, NSTEMI
• arterial thromboembolism prophylaxis
• ischemic stroke
• Stroke Risk Reduction
• acute myocardial infarction

Click on a drug below in order to find information and discounted prices at pharmacies near you.